HIMSSERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE

Hims & Hers

$37.00
-1.52% today · $8.23B mkt cap
Forensic verdict

Structurally Supported

Low risk. Claims align with the filings and valuation divergence is contained.

74%
Signal conviction
Hit rate: 83% · 18 trades
Fair-value divergence
-55.3%
Trading at a discount · fair value $81.91
Verification match
80/100
Claims vs. SEC filings
Epistemic drift
0/100
Story vs. disclosures
Source authority
77/100
Outlet credibility
Coordination
Organic spread
Cross-source timing & phrasing — score 0.
Price-impact probability
WKS +44
Neutral directional energy · ACS 81
Trading footprint
Moderate concern
Tape anomaly read — distinct from the narrative signal.
Narrative decay
2d half-life
Persistent regime
Today’s strategy signals
All strategies →
No named-playbook signal fired for HIMS today. These are short-term technical screens — most names don’t trigger on a given day.
Tracked price · last 90 sessions
Interactive Signal Lab →
Narrative under audit
“Hims & Hers Health Inc.'s summary on SWX provides general company information without a specific market thesis.”
Recent narratives tracked
01

Hims & Hers Health Inc.'s summary on SWX provides general company information without a specific market thesis.

02

Hims & Hers Health stock is slipping as investors continue to weigh concerns about margin pressure and the implications of recent financing activities.

03

Hims & Hers Health stock is declining as investors are concerned about margin pressure and recent financing activities.

04

Hims & Hers Health (HIMS) is experiencing business reacceleration and receiving analyst upgrades, indicating potential positive momentum.

05

TipRanks provides Hims & Hers Health, Inc. stock price, quote, news, and analysis.

06

Hims & Hers stock price increased following Barclays' decision to raise its price target for the company.

07

Hims & Hers Health Inc. has a public company profile on MarketWatch, indicating its status as a publicly traded entity.

08

Hims & Hers Health Inc. is an entity with a profile on MarketWatch.

Go deeper on Hims & Hers
Open the full interactive dossier — narrative clusters, price-impact dots, and the live Signal Lab.
Open full dossier

Forensic research, not investment advice. Scores reflect how the narrative holds up against the filings as of 2026-07-02.